◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Manulife Financial Corporation (0945) Revenue 2021–2025

Name: Manulife Financial Corporation (0945) revenue history 2021-2025
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-10-06

Manulife Financial Corporation annual revenue for fiscal 2025 was C$53.0 billion, compared with -C$7.3 billion in fiscal 2024. All figures are reported results from public filings — no estimates or projections.

0945 Annual Revenue

Revenue (annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Revenue	C$53.0B	(C$7.3B)	(C$7.0B)	C$24.2B	—

CAD; C$M / C$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

0945 Quarterly Revenue

Revenue (quarterly)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Total Revenue	C$19.7B	C$11.9B	C$8.6B	C$17.3B	C$41.1B	—

CAD; C$M / C$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Revenue at Comparable Companies

2318 Revenue — Ping An Insurance (Group) Company of China, Ltd.
2628 Revenue — China Life Insurance Company Limited
1299 Revenue — AIA Group Limited
ICICIPRULI Revenue — ICICI Life Insurance Limited
MFSL Revenue — Max Financial Services Limited
STARHEALTH Revenue — Star Health and Allied Insurance Company Limited

More 0945 metrics: Net Income · EPS · Free Cash Flow

All 0945 financial statements → Interactive 0945 charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.